Discover the 2023 ANRS MIE Activity report
Last updated on 08 October 2024
In brief
2023 was marked by a record volume of submissions to our calls for projects, an increase which reflects the high quality of our facilitation groups and committees, and the researchers and association partners who work with them. The agency’s dynamism is also illustrated by the development of new international sites and partnerships, the launch of a specific programme for the new generation of researchers and the implementation of major projects such as the France Vaccins programme.
You will know more about our five major scientific priorities within the fields of HIV/AIDS, hepatitis, tuberculosis and sexually transmitted infections. You can also find out about all our current research projects, including RHIVIERA, VISCONTI, TOPCHIB, VESPA, as well as structuring projects EMERGEN and AFROSCREEN, and the various national and international missions in which the agency is involved.
Contents
- Editorial
- Key figures for 2023
PART 1: Highlights of the agency’s scientific activity
- HIV/AIDS
- Viral hepatitis
- Sexually transmitted infections: Mpox, syphilis…
- Cross-sectional research on HIV/AIDS, viral hepatitis and STIs
- Tuberculosis
- Emerging infectious diseases (EID)
PART 2: Bringing together and facilitating communities
- Facilitation that covers the entire agency remit
- Supporting and facilitating the ANRS MIE international network
- Centralised pharmacovigilance and transfer of skills
- Work with civil society and patient associations
- Scientific events and meetings supported by the agency
PART 3: Funding, structuring and coordinating
- Research funding: diversifying calls for proposals
- Structuring: research networks and infrastructure
- Agency commitments
- Crisis preparedness and response, and research coordination during epidemic periods
PART 4: Organisation and governance
- The budget and its use
- Human resources
- The different agency bodies
PART 5: Selective bibliography
